Welcome to our dedicated page for ISPIRE TECHNOLOGY news (Ticker: ISPR), a resource for investors and traders seeking the latest updates and insights on ISPIRE TECHNOLOGY stock.
Ispire Technology Inc. (NASDAQ: ISPR) generates a steady flow of news centered on vaping technology, precision dosing and regulatory engagement across nicotine and cannabis markets. As a tobacco manufacturing company focused on e‑cigarettes and cannabis vaping hardware, its announcements often highlight product launches, manufacturing milestones and developments in age‑verification technology.
Company news frequently covers the evolution of its Aspire and Ispire product lines, including detailed hardware ecosystems for cannabis brands and structured device architectures unveiled at major industry events such as MJBizCon. These updates describe new series of devices designed for different formulations, performance requirements and use cases, reflecting Ispire’s emphasis on hardware engineering and ODM partnerships.
Ispire’s press releases also address regulatory and compliance themes. The company and its joint venture IKE Tech LLC report on progress with FDA submissions, including a component Pre‑Market Tobacco Product Application (PMTA) for a blockchain‑enabled age‑verification chip, as well as responses to policy actions targeting illicit vape markets and youth access. Additional coverage includes conference participation in nicotine delivery and cannabis capital events, where company executives discuss harm reduction, identity verification and market trends within regulated ENDS and cannabis hardware sectors.
Operational updates, such as the interim nicotine manufacturing license in Malaysia and statements from Ispire Malaysia about export‑only manufacturing and regulatory compliance, provide further context on the company’s manufacturing footprint and strategic initiatives. Investors, analysts and industry participants can use this news feed to follow Ispire’s product roadmap, regulatory interactions, manufacturing expansion and joint‑venture activities. Bookmark this page to monitor ongoing announcements, event participation and technology disclosures related to ISPR.
Ispire Technology (NASDAQ: ISPR) and IKE Tech responded to the U.S. Food and Drug Administration's new enforcement direction under the Nov. 17, 2025 continuing resolution that requires the FDA to allocate at least $200 million of its $712 million in user fees to ENDS enforcement and to fund a multi-agency task force with $2 million for removing illegal imports.
Both companies promoted their blockchain-enabled, FDA-submitted System-on-a-Chip and age-verification solutions as technology to enable real-time product tracing, device-level identity validation, and interoperability to curb illicit disposable vapes and protect youth in the $30 billion flavored vape market.
Ispire Technology (NASDAQ: ISPR) will host its fiscal first quarter 2026 earnings conference call at 8:00 am ET on Thursday, November 6, 2025 to discuss results for the quarter ended September 30, 2025.
Dial-in numbers: US 844-826-3033 or International +1 412-317-5185; ask for the "Ispire Technology Call." The call will be webcast live at https://viavid.webcasts.com/starthere.jsp?ei=1738889&tp_key=82f919c8ba (register 15 minutes early to install audio software).
A replay will be available through midnight ET on Thursday, November 20, 2025 via dial 844-512-2921 or +1 412-317-6671 using passcode 10203874.
Ispire Technology Inc. (NASDAQ: ISPR) reported challenging financial results for fiscal year 2025, with revenue declining to $127.5 million from $151.9 million in FY2024. The company's strategic shift from cannabis to nicotine sectors led to decreased gross profit of $22.6 million and widened net loss to $39.2 million.
Key developments include progress in PMTA activities through IKE Tech LLC joint venture, featuring blockchain-based age verification technology. The company reported $18M in backlog orders entering Q1 2026 and implemented cost-cutting measures resulting in $10.2 million in annual payroll savings. As of June 30, 2025, Ispire maintained $24.4 million in cash and cash equivalents with working capital of $0.4 million.
Ispire Technology (NASDAQ: ISPR), a leader in vaping technology and precision dosing, has scheduled its fiscal fourth quarter and full year 2025 earnings conference call for September 16, 2025, at 8:00 AM ET.
The call will discuss financial results for the period ended June 30, 2025. Investors can access the call through North American toll-free number (877-451-6152) or International number (+1 201-389-0879). A live webcast will be available, and a replay will be accessible until September 30, 2025, using passcode 13755309.
Ispire Technology Inc. (NASDAQ: ISPR) has secured a groundbreaking interim license from the Malaysian Government for nicotine product manufacturing. The company becomes the first and only entity in Malaysia with comprehensive authorization for export, import, and production of nicotine products.
The interim license enables immediate commencement of manufacturing operations. Ispire plans to expand its Malaysian facility from the current 6 production lines to 80 lines. The company expects to receive the final license in the coming months, completing its regulatory requirements in Malaysia.
This strategic move aims to diversify Ispire's production base and mitigate geopolitical pricing risks, positioning the company as a leading international vaping hardware provider.